Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 174
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Weekly Psychedelic Policy Briefing – August 16, 2026
Horizons: Perspectives on Psychedelics
Credentials, Clinics, and Costs: Stakeholders Respond to HRSA’s Psychedelic Therapy RFI
Scoop: Johnson & Johnson to Lead Delix Therapeutics’ $85M Series C
Paving the Way: Husseini Manji on Spravato’s Lessons for Psychedelic Drug Development
PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support...
Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed...
Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved...
MindMed Strengthens Board with Appointment of Two New Independent Directors
Opinions | Hallucinations of Meaning: If you can lie, so can...
PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act,...
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
Can Psilocybin Treat Obesity? New Evidence, Future Directions
Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression...
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders
Load more